Literature DB >> 530552

Videopupillographic and VER investigations in patients with congenital and acquired lesions of the optic radiation.

K U Hamann, K A Hellner, A Müller-Jensen, S Zschocke.   

Abstract

In 9 patients with congenital and acquired lesions of the optic radiation, videopupillographic investigations have been employed to determine the pupillographic threshold in the homonymous field defect. The study includes 3 patients suffering from congenital porencephalic cysts. The pupillary response was graded as akinetic, hypokinetic or eukinetic. These classifications yield some diagnostic clues as to the nature of the lesion. An attempt was made using the VER response in these patients to correlate the findings.

Entities:  

Mesh:

Year:  1979        PMID: 530552     DOI: 10.1159/000308846

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Sensitivity of nasal and temporal hemiretinas in latent nystagmus and strabismus evaluated using the light reflex.

Authors:  H Sekiya; S Hasegawa; K Mukuno; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

2.  How sensitive is pupil campimetry in hemifield loss?

Authors:  Karolína Skorkovská; Helmut Wilhelm; Holger Lüdtke; Barbara Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-19       Impact factor: 3.117

3.  Relative Afferent Pupillary Defects in Homonymous Visual Field Defects Caused by Stroke of the Occipital Lobe Using Pupillometer.

Authors:  Go Takizawa; Atsushi Miki; Fumiatsu Maeda; Katsutoshi Goto; Syunsuke Araki; Tsutomu Yamashita; Yoshiaki Ieki; Junichi Kiryu; Kiyoshi Yaoeda
Journal:  Neuroophthalmology       Date:  2017-08-31

4.  Gaze-Contingent Flicker Pupil Perimetry Detects Scotomas in Patients With Cerebral Visual Impairments or Glaucoma.

Authors:  Marnix Naber; Carlien Roelofzen; Alessio Fracasso; Douwe P Bergsma; Mies van Genderen; Giorgio L Porro; Serge O Dumoulin
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.